glutathione binding S-transferase Table 1 from Inhibition and

doi:10.1074/jbc.M602770200

Patients with diabetes, for example, need to monitor their carbohydrate intake

Cet entretien nest pas une consultation mdicale

While FDA-approved GLP-1 RAs have transformed the treatment landscape for obesity and diabetes through their effects on appetite, glycemic control, and weight reduction, glutathione may offer complementary benefits by addressing the oxidative stress component of metabolic dysfunction

Until data from such studies are available, physicians should carefully weigh the benefits against the risks, and use such concomitant therapy in these patients only extremely cautiously